Sofie Hædersdal

[Sofie Hædersdal @DersdalH]

@HenrikMaagensen, winner of the EASD Early Career Academy Best abstract prize elegantly guides us through HNF1A-MODY (MODY3) and the use of SGLT2-inhibitors with similar glucose excretion compared with type 2 diabetes
@Stenodiabetes
#EASD2024
#CardioMetabolicPrevention

[Andreas Andersen @1A_Andersen]

Excellent presentations by @Hagelqvist72567 and @KaisarMaytham that created a lot of attention at the big stage in Madrid Hall #EASD2024 @Stenodiabetes #CardioMetabolicPrevention @TinaVilsb @Christi04644231

[Sofie Hædersdal @DersdalH]

@DanielJDrucker @Filip_Knop Full text link available
https://t.co/sjqih6CZHN

[Sofie Hædersdal @DersdalH]

A huge thanks to @DanielJDrucker and @Filip_Knop for sharing 🙏

[Daniel J Drucker @DanielJDrucker]

One can never have enough glucagon-new perspectives from the experts #diabetes #obesity #NASH @UCPH_Research @Filip_Knop @NatureRevEndo https://t.co/uACSFbbycd